Categories: Healthcare, Pharmaceutical, Medical Devices, and Biotechnology | Report Code : HPMDB20268 | No. of Pages : 129
Overview:
The global birth control drugs market is valued for more than US$ XXX.X Mn in 2019 and expected to reach a value of US$ XXX.X Mn by 2029 with a significant CAGR of around XX.X% over the forecast period of 2019-2029. Birth control drugs are the medicines used to prevent pregnancy. These drugs are also called as fertility control drugs or contraceptive drugs. The birth control drugs include oral pills, injectable drugs, and topical drugs. These drugs play an important role in case of unwanted pregnancy or unprotected intercourse.
The drugs include two types of drugs one is combination drugs and progestin-only pills. The combination drugs include synthetic hormones and progestin-only pills contain progestin without estrogen.
Market Dynamics:
Growing concerns about family planning among young couples and rising incidences of unwanted pregnancies are key factors driving growth of the global birth control drugs market. Increasing population, growing education and children growth associated expenses, and increasing awareness about available drugs is resulting in the growth of target market.
In addition, rising incidence of early age pregnancy among teenagers and growing number of pregnancy associated issues are other major factors propelling growth of the target market.
Moreover, rising social media advertising and working women population are among the others factor supporting market growth. However, health issues associated with birth control drugs and availability of alternative options are key factors hampering growth of the global market. Additionally, incidences of drug recalls may hamper the target market growth. For example, in August 2020, Lupin Limited has recalled around 5.61 lac birth control tablet pouches from the US market under USFDA classified Class II recall.
Key Trends:
Growing number of product launches by major manufacturers to increase their market share is a key trend observed in the global birth control drugs market. For instance, in August 2018, Lupin Limited has launched birth control or contraceptive tablets viz. Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, and Levomefolate Calcium in the United States market.
Regional Analysis:
For detailed understanding of market dynamics, the global birth control drugs market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region is accounted for the major market share in the global market. This is associated with the rising number of unintended pregnancies and high awareness about the available drugs in the market among consumers. In addition, rising number of product launches by key players in countries in the region is another major factor propelling growth of the target market in the region.
However, the market in Asia Pacific is expected to witness significant growth during the forecast period. This is owing to increasing government initiative to control the growth of population in countries such as China and India. In addition, rising social awareness and benefits of birth control drugs are other key factors supporting the target market growth in the region.
Scope of the Report:
Report Feature |
Details |
Base Year: |
2018 |
Projection Period: |
2019-2029 |
Market Details: |
Total revenue and forecast, CAGR, Market value, share, and Y-o-Y growth by segment and region |
Segment Covered: |
Category, Product Type, and Distribution Channel |
Region Covered: |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Report Coverage: |
Market growth driving factors, challenges & pitfalls, opportunities, trends, key players analysis, and region analysis |
Detailed Segmentation:
Global Birth Control Drugs Market, By Category:
Global Birth Control Drugs Market, By Product Type:
Global Birth Control Drugs Market, By Distribution Channel:
Key Players Covered:
Key players operating in the global birth control drugs market includes Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Janssen Global Services, LLC, Merck & Co. Inc., Abbvie Inc. (Allergan Plc), Piramal Enterprises Ltd., Mylan N.V., Amneal Pharmaceuticals LLC, and Agile Therapeutics Inc.
Key Features of the Study:
Foresight Market Research provides detailed analysis on global market in our report- Global Birth Control Drugs Market by category, product type, distribution channel, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global birth control drugs market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, market expansion, and marketing tactics used overall the globe.